Mediwound Ltd
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -68.1% | -49.0% | -80.6% | -71.6% | -86.2% | -28.0% | -103.9% | -100.8% | -59.7% | -161.5% | -457.9% | -290.9% | -185.5% | |
| 7.1% | 6.5% | 7.4% | 7.1% | 8.3% | 6.8% | 9.1% | 6.9% | 7.7% | 37.0% | 25.6% | 13.0% | 15.9% | |
| 6.5% | 5.6% | 10.3% | 15.0% | 24.0% | 14.1% | 21.3% | 15.1% | 13.6% | 35.5% | 43.7% | 24.4% | 23.6% | |
| -11.3% | 18.0% | -36.2% | -6.0% | 2.3% | 56.0% | -1.6% | -19.3% | 42.4% | 194.2% | 51.3% | -34.3% | 47.4% | |
| 35.3% | 41.4% | 25.4% | 59.6% | 27.4% | 13.8% | 24.2% | 18.4% | 19.2% | 131.3% | 123.4% | 34.4% | 53.8% | |
| -122.0% | 94.2% | -48.1% | 56.2% | -328.0% | 82.7% | -84.5% | 85.9% | 80.7% | -1,279.6% | 1,203.8% | -81.6% | -36.1% | |
| – | – | – | – | – | – | – | – | – | -40.0% | – | – | – | |
| – | – | – | – | -5.2% | – | – | – | -6.1% | – | – | – | – | |
| -15.2% | -3.8% | -14.1% | -2.0% | 475.5% | -8.8% | -9.2% | 9.6% | 562.3% | -58.5% | -28.5% | 13.0% | 247.9% | |
| -207.0% | 48.5% | 474.1% | -17.7% | 61.7% | 45.9% | -197.1% | -5.3% | 583.5% | -1,496.4% | 715.4% | -1,303.4% | -219.3% | |
| -103.4% | -90.4% | -106.0% | -131.1% | -113.6% | -41.8% | -128.2% | -119.2% | -78.9% | -292.9% | -581.3% | -325.3% | -239.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.